Author Archives: Joana Fernandes, PhD

Pain Therapeutics’ PTI-125, Potential Treatment for Alzheimer’s, to Undergo Phase 1 Clinical Trial

Pain Therapeutics will soon launch a Phase 1 clinical trial to study the safety and efficacy of PTI-125 in treating Alzheimer’s disease. The announcement came after the U.S. Food and Drug Administration (FDA) accepted the company’s investigational new drug application for the therapy. It follows a recently awarded $1.7 million research grant by the…

Specific Genetic Factors Plus Unhealthy Diet Boost Risk of Alzheimer’s Disease, USC Study Finds

A high-fat, high-sugar diet may increase the risk of Alzheimer’s disease in people carrying the ApoE4 gene, according to a new study, “Obesity Accelerates Alzheimer-Related Pathology in APOE4 but Not APOE3 Mice,” that appeared in the journal eNeuro. Obesity is considered an environmental risk factor for Alzheimer’s, while the strongest genetic…

Aduhelm Approved